1 Min Read
Aug 7 (Reuters) - Nabriva Therapeutics Plc
* Nabriva Therapeutics reports second quarter 2017 financial results and recent corporate highlights
* Q2 loss per share $0.54 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.